Information Technology Reference
In-Depth Information
Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.J., Martin-Dupont, P., Michaud, P.,
Papo, T., Ugo, V., Teyssandier, I., Varet, B., and Mayeux, P. (2002) Pure red-cell aplasia
and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N. Engl.
J. Med. 346:469-475.
Chatenoud, L. (1993) Immunologic monitoring during OKT3 therapy. Clin. Transplant. 7(4
Pt 2):422-430.
Collen, D. (1996) Fibrin-selective thrombolytic therapy for acute myocardial infarction. Circula-
tion 93:857-865.
De Groot, A.S., Jesdale, B.M., Szu, E., and Schafer, J.R. (1997) An interactive Web site provid-
ing MHC ligand predictions: Application to HIV research. AIDS Res. Hum. Retroviruses
13:539-541.
De Groot, A.S., Bosma, A., Chinai, N., Frost, J., Jesdale, B.M., Gonzalez, M.A., Martin, W., and
Saint-Aubin, C. (2001a) From genome to vaccine: In silico predictions, ex vivo verification.
Vaccine 19:4385-4395.
De Groot, A.S., Saint Aubin, C.S., Rayner, J., and Martin, W. (2001b) Rapid determination of
HLA B*07- ligands from the West Nile Virus genome. Emerg. Infect. Dis. 7:706-713.
De Groot, A.S., and Martin, W. (2003a) From immunome to vaccine: Epitope mapping and
vaccine design tools. Novartis Found. Symp. 254:57-72.
De Groot, A.S., Jesdale, B., Martin, W., Saint-Aubin, C., Sbai, H., Bosma, A., Lieberman, J.,
Skowron, G., Mansourati, F., and Mayer, K.H. (2003b) Mapping cross-clade HIV-1 vaccine
epitopes using a bioinformatics approach. Vaccine 21:4486-4504.
Diamond, B. (2003) Speculations on the immunogenicity of self-proteins. Dev. Biol.
(Basel)112:29-34.
Elvin, J., Potter, C., Elliott, T., Cerundolo, V., and Townsend, A. (1993) A method to quantify
binding of unlabeled peptides to class I MHC molecules and detect their allele specificity. J.
Immunol. Methods 158:161-171.
Finkelman, F.D., Lees, A., and Morris, S.C. (1992) Antigen presentation by B lymphocytes to
CD4+ T lymphocytes in vivo: Importance for B lymphocyte and T lymphocyte activation.
Semin. Immunol. 4:247-255.
Forsthuber, T.G., Shive, C.L., Wienhold, W., de Graaf, K., Spack, E.G., Sublett, R., Melms, A.,
Kort, J., Racke, M.K., and Weissert, R. (2001) T-cell epitopes of human myelin oligoden-
drocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are
encephalitogenic and are presented by human B cells. J. Immunol. 167:7119-7125.
Fowell, D., and Mason, D. (1993) Evidence that the T-cell repertoire of normal rats contains cells
with the potential to cause diabetes. Characterization of the CD4+ T-cell subset that inhibits
this autoimmune potential. J. Exp. Med. 177:627-636.
Haselbeck, A. (2003) Epoetins: Differences and their relevance to immunogenicity. Curr. Med.
Res. Opin. 19:430-432.
Hill, A.V., Jepson, A., Plebanski, M., and Gilbert, S.C. (1997) Genetic analysis of host-parasite
coevolution in human malaria. Philos. Trans. R. Soc. London Ser. B 352:
1317-1325.
Jensen, P.B., Birkeland, S.A., Rohrp, N., Elbirk, A., and Jorgensen, K.A. (1996) Development of
anti-OKT3 antibodies after OKT3 treatment. Scand. J. Urol. Nephrol. 30:227-230.
Josic, D., Buchacher, A., Kannicht, C., Lim, Y.P., Loster, K., Pock, K., Robinson, S., Schwinn, H.,
and Stadler, M. (1999) Degradation products of factor VIII which can lead to increased im-
munogenicity. Vox Sang. 77(Suppl. 1):90.
Kappler, J.W., Roehm, N., and Marrack, P. (1987) T-cell tolerance by clonal elimination in the
thymus. Cell 49:273-280.
Kast, W.M., Brandt, R.M., Sidney, J., Drijfhout, J.W., Kubo, R.T., Grey, H.M., Melief, C.J., and
Sette, A. (1994) Role of HLA-A motifs in identification of potential CTL epitopes in human
papillomavirus type 16 E6 and E7 proteins. J. Immunol. 152:3904-3912.
